126 related articles for article (PubMed ID: 34478957)
1. Acylation of antimicrobial peptide-plasmid DNA vectors formulation for efficient gene delivery in cancer therapy.
Li Y; Sun Y; Dong W; Zhu C; Guan Y; Shang D
Colloids Surf B Biointerfaces; 2021 Dec; 208():112069. PubMed ID: 34478957
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity and self-assembly behavior of antimicrobial peptide chensinin-1b with lipophilic alkyl tails.
Dong W; Liu Z; Sun L; Wang C; Guan Y; Mao X; Shang D
Eur J Med Chem; 2018 Apr; 150():546-558. PubMed ID: 29549839
[TBL] [Abstract][Full Text] [Related]
3. Effect of hydrophobicity on distinct anticancer mechanism of antimicrobial peptide chensinin-1b and its lipoanalog PA-C1b in breast cancer cells.
Guo F; Zhang Y; Dong W; Guan Y; Shang D
Int J Biochem Cell Biol; 2022 Feb; 143():106156. PubMed ID: 34999227
[TBL] [Abstract][Full Text] [Related]
4. Binding Properties of DNA and Antimicrobial Peptide Chensinin-1b Containing Lipophilic Alkyl Tails.
Dong W; Luo X; Sun Y; Li Y; Wang C; Guan Y; Shang D
J Fluoresc; 2020 Jan; 30(1):131-142. PubMed ID: 31925652
[TBL] [Abstract][Full Text] [Related]
5. Acylation of the antimicrobial peptide CAMEL for cancer gene therapy.
Song J; Ma P; Huang S; Wang J; Xie H; Jia B; Zhang W
Drug Deliv; 2020 Dec; 27(1):964-973. PubMed ID: 32611259
[TBL] [Abstract][Full Text] [Related]
6. Targeted antimicrobial peptide delivery in vivo to tumor with near infrared photoactivated mesoporous silica nanoparticles.
Dong W; Wen J; Li Y; Wang C; Sun S; Shang D
Int J Pharm; 2020 Oct; 588():119767. PubMed ID: 32800935
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity analysis and biological studies of chensinin-1b analogues.
Dong W; Dong Z; Mao X; Sun Y; Li F; Shang D
Acta Biomater; 2016 Jun; 37():59-68. PubMed ID: 27060618
[TBL] [Abstract][Full Text] [Related]
8. Development of lipopolyplexes for gene delivery: A comparison of the effects of differing modes of targeting peptide display on the structure and transfection activities of lipopolyplexes.
Bofinger R; Zaw-Thin M; Mitchell NJ; Patrick PS; Stowe C; Gomez-Ramirez A; Hailes HC; Kalber TL; Tabor AB
J Pept Sci; 2018 Dec; 24(12):e3131. PubMed ID: 30325562
[TBL] [Abstract][Full Text] [Related]
9. Insights into the membrane interaction mechanism and antibacterial properties of chensinin-1b.
Sun Y; Dong W; Sun L; Ma L; Shang D
Biomaterials; 2015 Jan; 37():299-311. PubMed ID: 25453959
[TBL] [Abstract][Full Text] [Related]
10. Novel luminescent silica nanoparticles (LSN): p53 gene delivery system in breast cancer in vitro and in vivo.
Rejeeth C; Salem A
J Pharm Pharmacol; 2016 Mar; 68(3):305-15. PubMed ID: 27085860
[TBL] [Abstract][Full Text] [Related]
11. Functional delivery of large genomic DNA to human cells with a peptide-lipid vector.
White RE; Wade-Martins R; Hart SL; Frampton J; Huey B; Desai-Mehta A; Cerosaletti KM; Concannon P; James MR
J Gene Med; 2003 Oct; 5(10):883-892. PubMed ID: 14533197
[TBL] [Abstract][Full Text] [Related]
12. Cancer gene therapy mediated by RALA/plasmid DNA vectors: Nitrogen to phosphate groups ratio (N/P) as a tool for tunable transfection efficiency and apoptosis.
Neves AR; Sousa A; Faria R; Albuquerque T; Queiroz JA; Costa D
Colloids Surf B Biointerfaces; 2020 Jan; 185():110610. PubMed ID: 31711736
[TBL] [Abstract][Full Text] [Related]
13. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.
Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK
Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199
[TBL] [Abstract][Full Text] [Related]
14. Synergistic gene and drug tumor therapy using a chimeric peptide.
Han K; Chen S; Chen WH; Lei Q; Liu Y; Zhuo RX; Zhang XZ
Biomaterials; 2013 Jun; 34(19):4680-9. PubMed ID: 23537665
[TBL] [Abstract][Full Text] [Related]
15. Avidin-biotin interaction mediated peptide assemblies as efficient gene delivery vectors for cancer therapy.
Qu W; Chen WH; Kuang Y; Zeng X; Cheng SX; Zhou X; Zhuo RX; Zhang XZ
Mol Pharm; 2013 Jan; 10(1):261-9. PubMed ID: 23146022
[TBL] [Abstract][Full Text] [Related]
16. Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC.
Kim CK; Choi EJ; Choi SH; Park JS; Haider KH; Ahn WS
Gynecol Oncol; 2003 Aug; 90(2):265-72. PubMed ID: 12893186
[TBL] [Abstract][Full Text] [Related]
17. Tumor targeting RGD conjugated bio-reducible polymer for VEGF siRNA expressing plasmid delivery.
Kim HA; Nam K; Kim SW
Biomaterials; 2014 Aug; 35(26):7543-52. PubMed ID: 24894645
[TBL] [Abstract][Full Text] [Related]
18. Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector.
Huang H; Yu H; Tang G; Wang Q; Li J
Biomaterials; 2010 Mar; 31(7):1830-8. PubMed ID: 19942284
[TBL] [Abstract][Full Text] [Related]
19. A cationic cholesterol based nanocarrier for the delivery of p53-EGFP-C3 plasmid to cancer cells.
Misra SK; Naz S; Kondaiah P; Bhattacharya S
Biomaterials; 2014 Jan; 35(4):1334-46. PubMed ID: 24211075
[TBL] [Abstract][Full Text] [Related]
20. Transduction efficiency of pantropic retroviral vectors is controlled by the envelope plasmid to vector plasmid ratio.
Chen Y; Miller WM; Aiyar A
Biotechnol Prog; 2005; 21(1):274-82. PubMed ID: 15903266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
